Stock listing
B3:N1BI34 Neurocrine Biosciences, Inc. Ações
Brazilian listing (B3) of Neurocrine Biosciences, Inc. · home listing NASDAQ:NBIX
Follow Neurocrine Biosciences, Inc. into a list and get an email when it puts out news.
Share price · BMFBOVESPA:N1BI34
45.12 BRL -0.03 (-0.1%)
Close on Nov 6, 2026
- Day range
- 44.92 – 45.40 BRLNov 6, 2026
- Volume
- 230 sharesNov 6, 2026
- Market cap
- 91.73B BRLAt the close on Nov 6, 2026 · price × 2.03B shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NBIX · Home | $166.05 USD | +1.20 (+0.7%) | 2,220,260 | $166.36 | $169.02 | $162.02 | $164.85 | Close on Nov 4, 2026 |
| Frankfurt:NB3 | €141.60 EUR | -3.55 (-2.4%) | — | €141.60 | €141.60 | €141.60 | €145.15 | Close on Nov 6, 2026 |
| LSE:0K6R | $164.64 USD | +2.63 (+1.6%) | 629 | $161.32 | $165.84 | $158.76 | $162.01 | Close on Nov 6, 2026 |
| B3:N1BI34 | 45.12 BRL | -0.03 (-0.1%) | 230 | 45.00 | 45.40 | 44.92 | 45.15 | Close on Nov 6, 2026 |
| Munich:NB3 | €144.45 EUR | -0.70 (-0.5%) | — | €144.45 | €144.45 | €144.45 | €145.15 | Close on Nov 6, 2026 |
- Ticker
- B3:N1BI34
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · Nov 5, 2026
Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules
Latest earnings call · Nov 2, 2026
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 2, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Calls
Replays
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Q3 2026 Earnings Presentation
Earnings · 15 slides · Nov 2, 2026
Q1 2026 Earnings Presentation
Earnings · 15 slides · May 5, 2026
Merger or Acquisition (April 2026)
Merger or acquisition · 12 slides · Apr 6, 2026
Q4 2025 Earnings Presentation
Earnings · 71 slides · Feb 11, 2026
Neurocrine Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 56 in the last 12 months · 279 in all · newest Nov 5, 2026 · oldest 2019
- Calls
- 17 calls with a replay · 17 with a transcript · latest Nov 2, 2026
- Decks
- 17 decks · latest Nov 2, 2026
Where Neurocrine Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NBIX · Home listing | NASDAQ | United States | USD |
| gettex:NB3 | gettex | Germany | EUR |
| Lang & Schwarz:900964 | Lang & Schwarz | Germany | EUR |
| Frankfurt:NB3 | Frankfurt | Germany | EUR |
| LS Exchange:900964 | LS Exchange | Germany | EUR |
| BMV:NBIX | BMV | Mexico | MXN |
| LSE:0K6R | LSE | United Kingdom | USD |
| B3:N1BI34 · This page | B3 | Brazil | BRL |
| Tradegate:NB3 | Tradegate | Germany | EUR |
| Milan:1NBIX | Milan | Italy | EUR |
| BIVA:NBIX | BIVA | Mexico | MXN |
| BOATS:NBIX | BOATS | United States | USD |
| BX Swiss:NB3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:NB3 | Dusseldorf | Germany | EUR |
| Munich:NB3 | Munich | Germany | EUR |
| Stuttgart:NB3 | Stuttgart | Germany | EUR |
| Hamburg:NB3 | Hamburg | Germany | EUR |
| Hanover:NB3 | Hanover | Germany | EUR |
| Xetra:NB3 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurocrine Biosciences, Inc.